Cadence Bank Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS In Line

Advertisement

Cadence Bank (NYSE:CADE) Second Quarter 2025 Results

Key Financial Results

  • Revenue: US$445.3m (up 2.4% from 2Q 2024).
  • Net income: US$129.9m (down 3.8% from 2Q 2024).
  • Profit margin: 29% (down from 31% in 2Q 2024). The decrease in margin was driven by higher expenses.
  • EPS: US$0.69 (down from US$0.74 in 2Q 2024).
earnings-and-revenue-growth
NYSE:CADE Earnings and Revenue Growth July 25th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Cadence Bank Revenues Beat Expectations

Revenue exceeded analyst estimates by 2.0%. Earnings per share (EPS) was mostly in line with analyst estimates.

Looking ahead, revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 7.4% growth forecast for the Banks industry in the US.

Performance of the American Banks industry.

The company's share price is broadly unchanged from a week ago.

Balance Sheet Analysis

Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We have a graphic representation of Cadence Bank's balance sheet and an in-depth analysis of the company's financial position.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NYSE:CADE

Cadence Bank

Provides commercial banking and financial services in the United States.

Flawless balance sheet established dividend payer.

Advertisement

Weekly Picks

ST
stuart_roberts
UNCY logo
stuart_roberts on Unicycive Therapeutics ·

Looking to be second time lucky with a game-changing new product

Fair Value:US$21.5362.1% undervalued
132 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative
DE
Degen_GCR
P logo
Degen_GCR on Everpure ·

Second order memory play likely to double in a year

Fair Value:US$18053.7% undervalued
5 users have followed this narrative
0 users have commented on this narrative
2 users have liked this narrative
DO
Double_Bubbler
LUNR logo
Double_Bubbler on Intuitive Machines ·

Intuitive Machines: To The Moon and Beyond!

Fair Value:US$42.324.1% undervalued
5 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative
YI
APP logo
yiannisz on AppLovin ·

AppLovin’s AI Engine Is Printing Profit

Fair Value:US$989.2450.4% undervalued
22 users have followed this narrative
1 users have commented on this narrative
1 users have liked this narrative

Updated Narratives

OI
MVO logo
Oily on MV Oil Trust ·

Poor analysis here will mislead investors

Fair Value:US$2.11.0% undervalued
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
ZH
zhalia
LYC logo
zhalia on Lynas Rare Earths ·

Lynas Rare Earths to Shine with 281% Future P/E Surge

Fair Value:AU$22.8714.7% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
KA
kapirey
ROP logo
kapirey on Roche Holding ·

Roche is a cash-generating, defensive large-cap pharma, with upside driven by pipeline execution.

Fair Value:CHF 353.349.0% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

GO
QS logo
GoldenSands on QuantumScape ·

QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

Fair Value:US$8590.1% undervalued
108 users have followed this narrative
2 users have commented on this narrative
31 users have liked this narrative
KI
NVDA logo
Kingman1152 on NVIDIA ·

NVIDIA will see a profit margin surge of 55% in the next 5 years

Fair Value:US$305.227.7% undervalued
70 users have followed this narrative
2 users have commented on this narrative
24 users have liked this narrative
TR
tripledub
META logo
tripledub on Meta Platforms ·

The $135 Billion Bet That Should Make Every Shareholder Nervous

Fair Value:US$74018.5% undervalued
35 users have followed this narrative
3 users have commented on this narrative
33 users have liked this narrative